Herald Investment Management Ltd acquired a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 7,417 shares of the medical instruments supplier's stock, valued at approximately $977,000. Herald Investment Management Ltd owned approximately 0.14% of Mesa Laboratories at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the stock. XTX Topco Ltd boosted its holdings in Mesa Laboratories by 13.3% in the fourth quarter. XTX Topco Ltd now owns 3,382 shares of the medical instruments supplier's stock valued at $446,000 after acquiring an additional 398 shares during the last quarter. Barclays PLC boosted its stake in shares of Mesa Laboratories by 4.8% in the 4th quarter. Barclays PLC now owns 9,262 shares of the medical instruments supplier's stock valued at $1,222,000 after purchasing an additional 425 shares during the last quarter. Kennedy Capital Management LLC grew its position in shares of Mesa Laboratories by 13.2% during the 4th quarter. Kennedy Capital Management LLC now owns 74,606 shares of the medical instruments supplier's stock worth $9,838,000 after buying an additional 8,700 shares during the period. Raymond James Financial Inc. bought a new stake in shares of Mesa Laboratories during the fourth quarter worth approximately $32,677,000. Finally, Resona Asset Management Co. Ltd. acquired a new position in Mesa Laboratories in the fourth quarter valued at approximately $92,000. 90.60% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of Mesa Laboratories stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the completion of the transaction, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at $5,369,887.67. The trade was a 32.64 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.40% of the stock is currently owned by corporate insiders.
Mesa Laboratories Trading Up 3.2 %
MLAB traded up $3.61 during midday trading on Wednesday, reaching $116.65. 48,638 shares of the company were exchanged, compared to its average volume of 39,308. The stock has a market capitalization of $633.88 million, a P/E ratio of -2.52 and a beta of 0.92. The stock's 50-day simple moving average is $125.56 and its 200 day simple moving average is $127.35. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. Mesa Laboratories, Inc. has a one year low of $83.68 and a one year high of $155.12.
Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share for the quarter, beating analysts' consensus estimates of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. As a group, analysts forecast that Mesa Laboratories, Inc. will post 8 earnings per share for the current fiscal year.
Mesa Laboratories Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories's dividend payout ratio is currently -1.38%.
Mesa Laboratories Profile
(
Free Report)
Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
Further Reading
Before you consider Mesa Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.
While Mesa Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
